Merck, Glenmark Stifled Cholesterol Drug Market, Suit Says
Law360, Los Angeles (January 17, 2018, 9:05 PM EST) -- Merck & Co. and generics manufacturer Glenmark Pharmaceuticals Inc. were hit with a putative class action in Virginia federal court Wednesday claiming an agreement to keep a generic version of cholesterol...
To view the full article, register now.
Try Law360 FREE for seven days
Already a subscriber? Click here to login
